Oncogene-Induced Senescence in Pituitary Adenomas—an Immunohistochemical Study
- 375 Downloads
Oncogene-induced senescence (OIS) serves as an initial barrier to cancer development, being proposed as a possible explanation for the usually benign behavior of the pituitary adenomas. We aimed to explore the immunohistochemical expression of the OIS markers, senescence-associated lysosomal β-galactosidase (SA-β-GAL), p16, and p21 in different types of 345 pituitary adenomas and compared it with the expression in the normal pituitary and in the specimens from the repeated surgeries. SA-β-GAL was overexpressed in the pituitary adenomas, compared to the normal pituitaries. Growth hormone (GH) producing adenomas showed the strongest SA-β-GAL, with densely granulated (DG)-GH adenomas more reactive than the sparsely granulated (SG). Nuclear p21 was decreased in the adenomas, except for the SG-GH adenomas that had higher p21 than the normal pituitaries and the other adenomas. p16 was significantly lower in the adenomas, without type-related differences. SA-β-GAL was slightly lower and p16 slightly higher in the recurrences. Our findings indicate alterations of the senescence program in the different types of pituitary adenomas. Activation of senescence in the pituitary adenomas presents one possible explanation for their usually benign behavior, at least in the GH adenomas that show a synchronous increase of two OIS markers. However, subdivision into GH adenoma subtypes reveals differences that reflect complex regulatory mechanisms influenced by the interplay between the granularity pattern and the hormonal factors, with possible impact on the different clinical behavior of the SG- and DG-GH adenoma subtypes. p16 seems to have a more prominent role in the pituitary tumorigenesis than in the senescence. Recurrent growth in a subset of the pituitary adenomas is not associated with consistent changes in the senescence pattern.
KeywordsPituitary adenoma Oncogene-induced senescence GH adenomas granulation pattern Immunohistochemistry
This work was supported by the Ministry of Education and Science of Republic of Serbia, Grant No 175033. Part of this study performed within the Human Protein Atlas was supported by funding from the Knut and Alice Wallenberg Foundation. We thank Dijana Cerjan for assistance with the immunohistochemical analysis of beta-galactosidase.
Compliance with Ethical Standards
Conflict of Interest
Authors declare that they have no conflict of interest.
- 3.Alexandraki KI, Munayem Khan M, Chahal HS, Dalantaeva NS, Trivellin G, Berney DM, Caron P, Popovic V, Pfeifer M, Jordan S, Korbonits M, Grossman AB (2012) Oncogene-induced senescence in pituitary adenomas and carcinomas. Hormones (Athens, Greece) 11:297–307Google Scholar
- 26.Chesnokova V, Zhou C, Ben-Shlomo A, Zonis S, Tani Y, Ren SG, Melmed S (2013) Growth hormone is a cellular senescence target in pituitary and nonpituitary cells. Proceedings of the National Academy of Sciences of the United States of America 110:E3331-3339. doi: 10.1073/pnas.1310589110 PubMedCentralCrossRefPubMedGoogle Scholar
- 28.DeLellis RA (2004) Pathology and genetics of tumours of endocrine organs. World Health Organization classification of tumours, vol 8. IARC Press, LyonGoogle Scholar
- 29.Manojlovic Gacic E, Skender-Gazibara M, Soldatovic I, Dundjerovic D, Boricic N, Raicevic S, Popovic V (2015) Immunohistochemical expression of p16 and p21 in pituitary tissue adjacent to pituitary adenoma versus pituitary tissue obtained at autopsy: is there a difference? Endocrine Pathology 26:104–110. doi: 10.1007/s12022-015-9358-7 CrossRefPubMedGoogle Scholar
- 31.Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Ponten F (2015) Proteomics. Tissue-based map of the human proteome. Science (New York, NY) 347:1260419. doi: 10.1126/science.1260419
- 34.Obari A, Sano T, Ohyama K, Kudo E, Qian ZR, Yoneda A, Rayhan N, Mustafizur Rahman M, Yamada S (2008) Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocrine Pathology 19:82–91. doi: 10.1007/s12022-008-9029-z CrossRefPubMedGoogle Scholar
- 35.Bakhtiar Y, Hirano H, Arita K, Yunoue S, Fujio S, Tominaga A, Sakoguchi T, Sugiyama K, Kurisu K, Yasufuku-Takano J, Takano K (2010) Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae. European journal of endocrinology / European Federation of Endocrine Societies 163:531–539. doi: 10.1530/eje-10-0586 CrossRefPubMedGoogle Scholar
- 37.Fougner SL, Casar-Borota O, Heck A, Berg JP, Bollerslev J (2012) Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly. Clin Endocrinol (Oxf) 76 (1):96–102. doi: 10.1111/j.1365-2265.2011.04163.x CrossRefGoogle Scholar
- 39.Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. European journal of endocrinology / European Federation of Endocrine Societies 156:203–216. doi: 10.1530/eje.1.02326 CrossRefPubMedGoogle Scholar
- 42.Bianchi-Smiraglia A, Nikiforov MA (2012) Controversial aspects of oncogene-induced senescence. Cell Cycle (Georgetown, Tex) 11:4147–4151. doi: 10.4161/cc.22589
- 44.Lekva T, Berg JP, Heck A, Lyngvi Fougner S, Olstad OK, Ringstad G, Bollerslev J, Ueland T (2013) Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recovery. PLoS One 8:e66927. doi: 10.1371/journal.pone.0066927 PubMedCentralCrossRefPubMedGoogle Scholar